DK3057571T3 - Protonpumpehæmmer-pastasammensætninger - Google Patents
Protonpumpehæmmer-pastasammensætninger Download PDFInfo
- Publication number
- DK3057571T3 DK3057571T3 DK13783629.2T DK13783629T DK3057571T3 DK 3057571 T3 DK3057571 T3 DK 3057571T3 DK 13783629 T DK13783629 T DK 13783629T DK 3057571 T3 DK3057571 T3 DK 3057571T3
- Authority
- DK
- Denmark
- Prior art keywords
- ppi
- paste
- subject
- compositions
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (3)
1. Stabil pastasammensætning, der omfatter: i) 1 til 45 vægt-% omeprazol, ii) 0,05 til 0,1 vægt-% af et alkanolamin-baseomdannende middel og iii) 54,9 til 98,95 vægt-% af et mineraloliebaseret vehikel med en densitet på ca. 0,769 g/mL til ca. 0,915 g/mL ved 15 °C målt ifølge ASTM D-1298 til anvendelse i behandling eller forebyggelse af mavesår hos et individ, hvori pastasammensætningen (a) er uden fortykkelsesmiddel og (b) administreres direkte som en oral farmaceutisk formulering til individet.
2. Sammensætning ifølge krav 1, hvori det alkanolaminbaseomdannende middel er monoethanolamin.
3. Sammensætning ifølge krav 1, hvori det mineraloliebaserede vehikel er flydende paraffin.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/GB2013/052730 WO2015055974A1 (en) | 2013-10-18 | 2013-10-18 | Proton pump inhibitor paste compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3057571T3 true DK3057571T3 (da) | 2019-04-15 |
Family
ID=49510431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK13783629.2T DK3057571T3 (da) | 2013-10-18 | 2013-10-18 | Protonpumpehæmmer-pastasammensætninger |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3057571B1 (da) |
DK (1) | DK3057571T3 (da) |
ES (1) | ES2717029T3 (da) |
PL (1) | PL3057571T3 (da) |
WO (1) | WO2015055974A1 (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018031935A1 (en) | 2016-08-11 | 2018-02-15 | Adamis Pharmaceuticals Corporation | Drug compositions |
EP3299017A1 (en) * | 2016-09-23 | 2018-03-28 | The Boots Company PLC | Formulation |
EP3720844A4 (en) | 2017-12-08 | 2021-08-11 | Adamis Pharmaceuticals Corporation | MEDICINAL COMPOSITIONS |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA004683B1 (ru) * | 1999-02-23 | 2004-06-24 | Мерк Энд Ко., Инк. | Фармацевтическая композиция, содержащая омепразол |
TWI232761B (en) * | 2000-07-01 | 2005-05-21 | Pharmaceutical Ind Tech & Dev | Capsule preparation for oral administration and the preparation method thereof |
WO2005000269A1 (en) * | 2003-06-26 | 2005-01-06 | Cipla Limited | Pharmaceutical formulations comprising a proton pump inhibitor |
-
2013
- 2013-10-18 PL PL13783629T patent/PL3057571T3/pl unknown
- 2013-10-18 EP EP13783629.2A patent/EP3057571B1/en active Active
- 2013-10-18 DK DK13783629.2T patent/DK3057571T3/da active
- 2013-10-18 WO PCT/GB2013/052730 patent/WO2015055974A1/en active Application Filing
- 2013-10-18 ES ES13783629T patent/ES2717029T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
EP3057571B1 (en) | 2019-03-06 |
EP3057571A1 (en) | 2016-08-24 |
ES2717029T3 (es) | 2019-06-18 |
PL3057571T3 (pl) | 2019-07-31 |
WO2015055974A1 (en) | 2015-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU230300B1 (hu) | Prosztaglandin E1 helyi beadásra alkalmas készítmények | |
EA026456B1 (ru) | Фармацевтическая композиция на основе антагониста crth2 и ингибитора протонного насоса для лечения эозинофильного эзофагита | |
US20230144845A1 (en) | Alpha-Ketobutyrate, 2-Hydroxybutyrate, and Alpha-Ketoglutarate for Stimulating Hair Growth | |
JP2011144168A (ja) | 非腸溶性酸不安定性薬物の液体剤形 | |
DK3057571T3 (da) | Protonpumpehæmmer-pastasammensætninger | |
CN110996949A (zh) | 用于治疗行为改变的方法 | |
JP2010138170A (ja) | 抗疲労組成物 | |
JP2012533633A (ja) | 経口投与のための安定な薬学的オメプラゾール製剤 | |
WO2014135956A1 (en) | Composition for use in the treatment of polycystic ovary syndrome | |
KR102419769B1 (ko) | 약물 조성물 | |
JP6178802B2 (ja) | 運動ニューロンのオートファジーを阻害するための医薬組成物およびその使用 | |
Stoskopf et al. | Pharmaceuticals and formularies | |
US8729026B2 (en) | Method for inhibiting autophagy of motor neurons | |
JP2024519342A (ja) | 自己免疫性、同種免疫性、炎症性、及びミトコンドリア性の状態を治療するための組成物、ならびにその使用 | |
CN104706636A (zh) | 一种阿苯达唑制剂及制备方法 | |
GB2524351A (en) | Proton Pump Inhibitor Paste Compositions | |
KR20220126426A (ko) | 안정성이 향상된 라베프라졸을 유효성분으로 포함하는 경구용 속방형 제제 및 이의 제조방법 | |
TW200400826A (en) | Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of GERD | |
WO2019197564A1 (en) | Mcoppb for use as medicament | |
JP6370634B2 (ja) | 男性不妊症の予防乃至治療薬、及び食品乃至飼料 | |
FR3069434A1 (fr) | Acide anthranilique dans le traitement de l'atrophie musculaire | |
US20230285344A1 (en) | SPECIALIZED PRO-RESOLVING MEDIATORS (SPMs) AS MELANOCYTE GROWTH PROMOTER AND PRO-SURVIVAL FACTORS AND USES THEREOF | |
JP2014001207A (ja) | 解熱鎮痛薬組成物 | |
KR20230137374A (ko) | 경로 조절제, 이를 갖는 약학 조성물, 이의 용도 및 이를 이용한 치료 방법 | |
JP5734134B2 (ja) | 抗疲労用医薬組成物 |